New Textbooks @ Talbot

Year: 2018
Title: Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
Place Published: Cham, Switzerland
Publisher: Springer
Notes: REF25 RD667.5 B743 2018

Year: 2019
Title: Operative Standards for Cancer Surgery: Volume 2 Thyroid, Gastric, Rectum, Esophagus, Melanoma
Place Published: Philadelphia, PA
Publisher: Wolters Kluwer, American College of Surgeons
Notes: REF25 RD651 .O64 2019 V2

Author: Aboumarzouk, Omar M.
Year: 2019
Title: Blandy’s Urology
Place Published: Hoboken, NJ
Publisher: John Wiley & Sons
Notes: REF25 RC871 .B53 2019

New Edition!
Author: Berek, Jonathan S.
Year: 2020
Title: Berek & Novak’s Gynecology
Place Published: Lippincott Williams & Wilkins
Notes: REF25 RG101 B45 2020
Includes bibliographical references and index

Author: Bland, K. I. and Klimberg, V. Suzanne
Year: 2019
Title: Breast Surgery
Series Title: Master techniques in surgery
Publisher: Wolters Kluwer Heatlh / Lippincott Williams Wilkins

Abstract: “Breast cancer represents the most common cancer that affects women of the industrial and impoverished nations of the world; this neoplasm has a lifetime risk to affect one in every eight women of the industrialized countries with various presentations and stages of disease. Surgical therapy remains one of the principal modalities utilized to treat this organ – centric cancer. Surgical treatment of breast cancer has evolved over the past century from radical debilitating surgeries to minimally- invasive approaches that have advanced with earlier diagnosis and highly- effective neoadjuvant therapies. These more plausible and highly acceptable minimally -invasive techniques have progressed from disfiguring procedures to reconstruction excellence. Moreover, the entire field of breast cancer surgery is advancing very rapidly globally, thus, many of the procedures illustrated in this text are not readily applied in community surgical practice and certainly not in such an eclectic textural format”–Provided by publisher
Notes: REF25 RD539.8 .B74 2019
Includes bibliographical references and index

New Edition!
Author: Greer, John P.
Year: 2019
Title: Wintrobe’s Clinical Hematology
Publisher: Lippincott Williams & Wilkins
Short Title: Wintrobe’s clinical hematology

Abstract: This extensive title, which combines scientific principles with up-to-date clinical procedures, has been thoroughly updated for the fourteenth edition. You’ll find in-depth material on the biology and pathophysiology of lymphomas, leukemias, platelet destruction, and other hematological disorders as well as the procedures for diagnosing and treating them. Combines the biology and pathophysiology of hematology as well as the diagnosis and treatment of commonly encountered hematological disorders in one volume. Access the latest knowledge in genetics and genomics. eBook features 300 online self-assessment questions for reviewing material and preparing for Board exams. Packed with more than 1,500 tables and figures.
Notes: REF25 RB145 .W74 2019

Author: Kaiser, Larry R., Jamieson, Glyn G. and Thompson, Sarah K.
Year: 2018
Title: Operative Thoracic Surgery
Series Title: Rob & Smith’s Operative Surgery Series
Place Published: Boca Raton, FL
Publisher: CRC Press of Taylor & Francis Group
Notes: REF25 RD536 .O64 2018
Separated from Rob & Smith’s operative surgery. 5th ed. 1993-[2006]; Dr. Larry Kaiser is Dean, Lewis Katz School of Medicine, Temple University; Includes bibliographical references

New Edition!
Author: Kliegman, Robert, Stanton, Bonita, StGeme, Joseph W., Schor, Nina Felice, Behrman, Richard E. and Nelson, Waldo E.
Year: 2020
Title: Nelson Textbook of Pediatrics
Place Published: Philadelphia, PA
Publisher: Elsevier Health Sciences
Notes: REF25 RJ45 .N4 2020 ( 2 vols)

New Edition!
Author: Niederhuber, John E., Armitage, James O., Doroshow, James H., Kastan, M. B., Tepper, Joel E. and Abeloff, Martin D.
Year: 2020
Title: Abeloff’s Clinical Oncology
Publisher: Elsevier Health Science

Abstract: “Easily accessible and clinically focused, Abeloff’s Clinical Oncology, 6th Edition, covers recent advances in our understanding of the pathophysiology of cancer, cellular and molecular causes of cancer initiation and progression, new and emerging therapies, current trials, and much more. Masterfully authored by an international team of leading cancer experts, it offers clear, practical coverage of everything from basic science to multidisciplinary collaboration on diagnosis, staging, treatment and follow up”–Publisher’s description
Notes: REF25 RC261 .C6512 2020

Author: Rubin, Emanuel and Reisner, Howard M.
Year: 2019
Title: Principles of Rubin’s Pathology
Publisher: Lippincott Williams & Wilkins
Notes: REF25 RB111 .E856 2019
Revision of: Essentials of Rubin’s pathology / editors, Emanuel Rubin, MD, Howard M. Reisner, PhD. 2014. 6th ed; Includes index; Machine generated contents note:; 1; Cell Adaptation, Injury, Death, and Aging; David Lombard –; 2; Inflammation and Repair; Jeffrey M. Davidson –; 3; Immunopathology; Sergio A. Jimenez –; 4; Neoplasia; Emanuel Rubin –; 5; Developmental and Genetic Diseases; Linda A. Cannizzaro –; 6; Infectious and Parasitic Diseases; David A. Schwartz –; 7; The Amyloidoses; Philip Hawkins –; 8; Blood Vessels and Hemodynamic Disorders; Robert Yanagawa –; 9; Heart; Jeffrey E. Saffitz –; 10; The Respiratory System; William D. Travis –; 11; The Gastrointestinal Tract; Frank Mitros –; 12; The Liver and Biliary System; Swan N. Thung –; 13; The Exocrine Pancreas; Edward B. Stelow –; 14; The Kidney; J. Charles Jennette –; 15; The Lower Urinary Tract and Male Reproductive System; Peter A. McCue –; 16; The Female Reproductive Tract; David A. Schwartz –; 17; The Breast; Frances P. O’Malley –; 18; Hematopathology; Robert Yanagawa –; 19; Endocrine System, Diabetes, and Nutritional Diseases; Elias S. Siraj –; 20; The Skin; David E. Elder –; 21; The Head and Neck; Diane L. Carlson –; 22; Bones, Joints, and Soft Tissue; Alan L. Schiller –; 23; Skeletal Muscle; Thomas W. Bouldin –; 24; The Central Nervous System and Eye; Gordon K. Klintworth –; 25; Traumatic and Environmental Injury; Emanuel Rubin

New Edition!
Author: Sadler, T. W.
Year: 2019
Title: Langman’s Medical Embryology
Publisher: Lippincott Williams & Wilkins
Short Title: Langman’s medical embryology
Notes: REF25 QM601 .S215 2019

New Edition!
Author: Steele, Scott R.
Year: 2019
Title: The ASCRS Manual of Colon and Rectal Surgery
Publisher: ASCRS (American Society of Colon and Rectal Surgeons), Springer
Notes: REF25 RD544 .A825 2019

Advertisements

What’s New Or On The Horizon.

Resource Changes from the NLM:

  • My Bibliography has a new look and different functionality.  Each account used to have My Bibliography and Other Citations, but they have been combined into one collection.  So if you are a PI on a grant, the papers that are associated to that grant, although not written by you, will be listed in your My Bibliography.  When I complained about this, NCBI wrote to say that one will be able to manipulate and filter for tags at some point, but the functionality is not yet available.  Delegates who manage My Bibliography for others must now go into their dashboard to add citations; they can no longer be added directly from the PubMed Search Screen.
  • NIHMS will receive an entire overhaul by Fall 2019.  The current system is the original that was put in place in 2005.  The new NIHMS will have a new user interface with fewer steps.  File uploads will transition to a drag and drop.  It’s supposed to be easier, faster, and speed up the process.
  • Linkout will transition to Outside Tool. Currently, Talbot uses Linkout with PubMed to identify our holdings (the Talbot Online icon).  Before the end of 2019, users will see a Talbot icon on every PubMed citation.  Clicking it will bring you to either the full-text of the article or an interlibrary loan form.   This will hopefully result in faster linking to full-text (yay!).
  • New PubMed! NLM expects to debut a new version of PubMed in September!  It will have a new modern look and new features.  They plan to have both systems in place until January, 2020.  For a peak, go to PubMed Labs

New Journals to be published:

  • Nature Research plans to launch Nature Cancer in January, 2020.  Nature Cancer will publish across the spectrum of the natural, applied and social sciences, from basic pre-clinical studies to translational and clinical work.
  • NEJM Group plans to launch NEJM Catalyst Innovations in Care Delivery, also in January.  This will be a peer-reviewed bimonthly subscription journal devoted to health care’s urgent problems and practical solutions.  They are saying that it will be a must read journal for everyone involved in leading and delivering health care.

Open Access News: 

“Plan U” Proposal

Scientists Call on Funders to Make Research Freely Available Immediately, “Plan U” (for Universal)

“In a new article in the open-access journal PLOS Biology, Richard Sever and John Inglis from Cold Spring Harbor Laboratory and Mike Eisen from UC Berkeley propose a new solution to these problems, which they call Plan U (for “universal”).

“They call on the organizations that fund research – government agencies such as NIH and charities like the Howard Hughes Medical Institute – to require the scientists they support to post drafts of their papers on free websites called “preprint servers” before submitting them to academic journals.”

https://www.infodocket.com/2019/06/04/scientists-call-on-funders-to-make-research-freely-available-immediately-plan-u-proposal-published-today/

The Dark Side of Open Access

The NY Times published an article on April 3, The Price for Predatory Publishing, that described recent judgment brought against Omics International.  The Federal Trade Commission was awarded $50 million against Omics and its owner.  The judge also ordered the company to “cease its deceptive business practices, including failure to disclose fees, misleading authors about the legitimacy of its journals and marketing conferences with star speakers who never agreed to participate.”

New Free Profiling Tool!  H-Index Fans Rejoice!

Clarivate, the folks who bring us Web of Science, have purchased Publons.  Researchers can register at no cost at publons.com and create a professional profile that can be public or private.  The unique thing about this, though, is that it automatically computes and updates the researcher’s H- Index! The easy way to set this up is to register for an account and then upload a file or go to web of science, search for your papers, and use the “export to Publons” feature.

Staff Publications: March 2019

  1. Amin A, Plimack ER, Ernstoff MS, Lewis LD, Bauer TM, McDermott DF, Carducci M, Kollmannsberger C, Rini BI, Heng DYC, Knox J, Voss MH, Spratlin J, Berghorn E, Yang L, Hammers HJ. Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Journal for immunotherapy of cancer, 7(1):73, 2019. PMC6416882
  2. Barone FC, Marcinkiewicz C, Li J, Feng Y, Sternberg M, Lelkes PI, Rosenbaum-Halevi D, Gerstenhaber JA, Feuerstein GZ. Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, particle distribution and excretion studies (part IV). International journal of nanomedicine, 14:1163-75, 2019. PMC6391148
  3. Blackwell KL, Zaman K, Qin S, Tkaczuk KHR, Campone M, Hunt D, Bryce R, Goldstein LJ, Study G. Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study. Clinical breast cancer, 19(2):97-104.e4, 2019.
  4. Blanke CD, Crowley J, Baker LH, Fisher RI. In Memoriam: Charles A. Coltman, 1930 to 2018. Journal of clinical oncology : official journal of the American Society of Clinical Oncology:Jco1900270, 2019.
  5. Chen OY, Cao H, Reinen JM, Qian T, Gou J, Phan H, De Vos M, Cannon TD. Resting-state brain information flow predicts cognitive flexibility in humans. Scientific reports, 9(1):3879, 2019. PMC6406001
  6. Cohn JA. Editorial Comment. The Journal of urology:10109701JU0000554404741846e, 2019.
  7. Cohn JA, Smith AL. Management of Occult Urinary Incontinence with Prolapse Surgery. Current urology reports, 20(5):23, 2019.
  8. DuBay DA, Ivankova NV, Herbey I, Redden DT, Holt C, Siminoff L, Fouad MN, Morinelli TA, Martin MY. An African American Perspective on Familial Notification of Becoming a Registered Organ Donor. Progress in transplantation (Aliso Viejo, Calif):1526924819835837, 2019.
  9. El-Deiry WS, Winer A, Slifker M, Taylor S, Adamson BJS, Meropol NJ, Ross EA. Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC). Frontiers in oncology, 9:142, 2019. PMC6426764
  10. Eze N, Lee JW, Yang DH, Zhu F, Neumeister V, Sandoval-Schaefer T, Mehra R, Ridge JA, Forastiere A, Chung CH, Burtness B. PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma. Oral oncology, 91:69-78, 2019.
  11. Fakhry C, Zhang Q, Gillison ML, Nguyen-Tan PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, 3rd, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, Fortin A, Raben D, Harris J, Le QT. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials. Cancer, 2019.
  12. Fang CY, Lee M, Feng Z, Tan Y, Levine F, Nguyen C, Ma GX. Community-Based Cervical Cancer Education: Changes in Knowledge and Beliefs Among Vietnamese American Women. Journal of community health, 2019.
  13. Ghosh J, Schultz B, Coutifaris C, Sapienza C. Highly variant DNA methylation in normal tissues identifies a distinct subclass of cancer patients. Advances in cancer research, 142:1-22, 2019.
  14. Gibney GT, Hamid O, Lutzky J, Olszanski AJ, Mitchell TC, Gajewski TF, Chmielowski B, Hanks BA, Zhao Y, Newton RC, Maleski J, Leopold L, Weber JS. Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma. Journal for immunotherapy of cancer, 7(1):80, 2019.
  15. Guindalini RS, Zheng YL, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova G, Liu F, Raoul A, Cao HY, Romero IL, Hong S, Livingston R, Jaskowiak N, Wang XM, Debiasi M, Pritchard CC, King MC, Karczmar G, Newstead GM, Huo D, Olopade OI. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clinical Cancer Research, 25(6):1786-94, 2019.
  16. Hall KW, Percec S, Klein ML. Polymer nucleation under high-driving force, long-chain conditions: Heat release and the separation of time scales. The Journal of chemical physics, 150(11):114901, 2019.
  17. Hayakawa K, Li YS, Shinton SA, Bandi SR, Formica AM, Brill-Dashoff J, Hardy RR. Crucial Role of Increased Arid3a at the Pre-B and Immature B Cell Stages for B1a Cell Generation. Frontiers in Immunology, 10, 2019.
  18. He AR, Cohen RB, Denlinger CS, Sama A, Birnbaum A, Hwang J, Sato T, Lewis N, Mynderse M, Niland M, Giles J, Wallin J, Moser B, Zhang W, Walgren R, Plimack ER. First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer. The oncologist, 2019.
  19. Kantidze OL, Luzhin AV, Nizovtseva EV, Safina A, Valieva ME, Golov AK, Velichko AK, Lyubitelev AV, Feofanov AV, Gurova KV, Studitsky VM, Razin SV. The anti-cancer drugs curaxins target spatial genome organization. Nature communications, 10(1):1441, 2019.
  20. Karpova Y, Wu C, Divan A, McDonnell ME, Hewlett E, Makhov P, Gordon J, Ye M, Reitz AB, Childers WE, Skorski T, Kolenko V, Tulin AV. Non-NAD-like PARP-1 inhibitors in prostate cancer treatment. Biochemical pharmacology, 2019.
  21. Kasagi Y, Dods K, Wang JX, Chandramouleeswaran PM, Benitez AJ, Gambanga F, Kluger J, Ashorobi T, Gross J, Tobias JW, Klein-Szanto AJ, Spergel JM, Cianferoni A, Falk GW, Whelan KA, Nakagawa H, Muir AB. Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α. Journal of Allergy and Clinical Immunology, 2019.
  22. Kaushik A, Yndart A, Atluri V, Tiwari S, Tomitaka A, Gupta P, Jayant RD, Alvarez-Carbonell D, Khalili K, Nair M. Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection. Scientific reports, 9(1):3928, 2019. PMC6408460
  23. Kentish-Barnes N, Siminoff LA, Walker W, Urbanski M, Charpentier J, Thuong M, Sarti A, Shemie SD, Azoulay E. A narrative review of family members’ experience of organ donation request after brain death in the critical care setting. Intensive care medicine, 45(3):331-42, 2019.
  24. Kiseleva AA, Korobeynikov VA, Nikonova AS, Zhang P, Makhov P, Deneka AY, Einarson MB, Serebriiskii IG, Liu H, Peterson JR, Golemis EA. Unexpected activities in regulating ciliation contribute to off-target effects of targeted drugs. Clinical cancer research : an official journal of the American Association for Cancer Research, 2019.
  25. Liao L, Alicea-Velázquez NL, Langbein L, Niu X, Cai W, Cho EA, Zhang M, Greer CB, Yan Q, Cosgrove MS, Yang H. High affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1. Molecular Oncology, 2019.
  26. Liu Y, Barta SK. Diffuse Large B cell Lymphoma: 2019 update on diagnosis, risk-stratification and treatment. American journal of hematology, 2019.
  27. Manne SL, Kashy DA, Zaider T, Kissane D, Lee D, Kim IY, Heckman CJ, Penedo FJ, Murphy E, Virtue SM. Couple-focused interventions for men with localized prostate cancer and their spouses: A randomized clinical trial. British journal of health psychology, 2019.
  28. Martin DDO, Kanuparthi PS, Holland SM, Sanders SS, Jeong HK, Einarson MB, Jacobson MA, Thomas GM. Identification of Novel Inhibitors of DLK Palmitoylation and Signaling by High Content Screening. Scientific reports, 9(1):3632, 2019. PMC6403299
  29. Martin JM, Wu H, Barta SK. CD30+ T-cell lymphoproliferative disorders. Chinese clinical oncology, 8(1):4, 2019.
  30. Martinez Chanza N, Xie W, Asim Bilen M, Dzimitrowicz H, Burkart J, Geynisman DM, Balakrishnan A, Bowman IA, Jain R, Stadler W, Zakharia Y, Narayan V, Beuselinck B, McKay RR, Tripathi A, Pachynski R, Hahn AW, Hsu J, Shah SA, Lam ET, Rose TL, Mega AE, Vogelzang N, Harrison MR, Mortazavi A, Plimack ER, Vaishampayan U, Hammers H, George S, Haas N, Agarwal N, Pal SK, Srinivas S, Carneiro BA, Heng DYC, Bosse D, Choueiri TK, Harshman LC. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study. The Lancet Oncology, 2019.
  31. Masic S, Smaldone MC. Treatment delays for muscle-invasive bladder cancer. Cancer, 2019. Editorial
  32. Mateo AM, Mazor AM, DeMora L, Sigurdson ER, Handorf EA, Daly JM, Aggon AA, Obeid E, Hayes SB, Bleicher RJ. Patterns of Care and Efficacy of Chemotherapy and Radiotherapy in Skin-Involved Breast Cancers of All Sizes. Clinical breast cancer, 2019.
  33. Matulonis UA, Birrer MJ, O’Malley DM, Moore KN, Konner J, Gilbert L, Martin LP, Bauer TM, Oza AM, Malek K, Pinkas J, Kim SK. Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. Clinical Cancer Research, 25(6):1727-36, 2019.
  34. Michael JV, Goldfinger LE. Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting. Seminars in Cancer Biology, 54:121-30, 2019.
  35. Milliron BJ, Bruneau M, Obeid E, Gross L, Bealin L, Smaltz C, Giri VN. Diet assessment among men undergoing genetic counseling and genetic testing for inherited prostate cancer: Exploring a teachable moment to support diet intervention. The Prostate, 2019.
  36. Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. Annals of surgical oncology, 2019.
  37. Modi V, Dunbrack RL, Jr. Defining a new nomenclature for the structures of active and inactive kinases. Proceedings of the National Academy of Sciences of the United States of America, 2019.
  38. Moore KN, Bendell JC, LoRusso PM, Olszanski AJ, Zwick-Wallasch E, Jansen M, Vandell AG, Senaldi G. First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors. Investigational New Drugs, 37(1):147-58, 2019.
  39. Mortazavi SMJ. Re: Microbiological colonization of healthcare workers’ mobile phones in a tertiary-level Italian intensive care unit. Intensive & critical care nursing, 2019. Letter
  40. Mortazavi SMJ. Acquired Antibiotic Resistance in Escherichia coli Exposed to Simulated Microgravity: Possible Role of Other Space Stressors and Adaptive Responses. mBio, 10(2), 2019. Letter
  41. Mortazavi SMJ, Bevelacqua JJ. Comment on “Using Flight-Time to Contextualize Radiological Dose”. Physics Teacher, 57(2):67, 2019.
  42. Mortazavi SMJ, Malakoutikhah M, Zare A, Tajvar A, Derakhshan Jazari M. Commentary regarding “Factors associated with mental health among high school students in Iran: Does mobile phone overuse associate with poor mental health?”. Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc, 2019. Comment
  43. Naito S, Ichiyanagi O, Ito H, Kabasawa T, Kanno H, Narisawa T, Fukuhara H, Yagi M, Kurota Y, Yamagishi A, Sakurai T, Nishida H, Kawazoe H, Yamanobe T, Kato T, Makhov P, Kolenko VM, Yamakawa M, Tsuchiya N. Expression of total and phospho 4EBP1 in metastatic and non-metastatic renal cell carcinoma. Oncology letters, 17(4):3910-8, 2019. PMC6403496
  44. Pang M, Koop A, Brahmbhatt B, Bartel MJ, Woodward TA. Comparison of flexible endoscopic cricopharyngeal myectomy and myotomy approaches for Zenker diverticulum repair. Gastrointestinal Endoscopy, 89(4):880-6, 2019.
  45. Patel D, Handorf E, von Mehren M, Martin L, Movva S. Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage. Sarcoma, 2019:3561501, 2019. PMC6387708
  46. Pope JL, Yang Y, Newsome RC, Sun W, Sun X, Ukhanova M, Neu J, Issa JP, Mai V, Jobin C. Microbial Colonization Coordinates the Pathogenesis of a Klebsiella pneumoniae Infant Isolate. Scientific reports, 9(1):3380, 2019. PMC6399262
  47. Reese JB, Sorice K, Lepore SJ, Daly MB, Tulsky JA, Beach MC. Patient-clinician communication about sexual health in breast cancer: A mixed-methods analysis of clinic dialogue. Patient Education and Counseling, 102(3):436-42, 2019.
  48. Regnante JM, Richie NA, Fashoyin-Aje L, Vichnin M, Ford M, Roy UB, Turner K, Hall LL, Gonzalez E, Esnaola N, Clark LT, Adams HC, 3rd, Alese OB, Gogineni K, McNeill L, Petereit D, Sargeant I, Dang J, Obasaju C, Highsmith Q, Lee SC, Hoover SC, Williams EL, Chen MS, Jr. US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials. Journal of oncology practice:Jop1800638, 2019.
  49. Rodriguez-Emmenegger C, Xiao Q, Kostina NY, Sherman SE, Rahimi K, Partridge BE, Li S, Sahoo D, Reveron Perez AM, Buzzacchera I, Han H, Kerzner M, Malhotra I, Moller M, Wilson CJ, Good MC, Goulian M, Baumgart T, Klein ML, Percec V. Encoding biological recognition in a bicomponent cell-membrane mimic. Proceedings of the National Academy of Sciences of the United States of America, 116(12):5376-82, 2019. PMC6431222
  50. Rosenthal SA, Hu C, Sartor O, Gomella LG, Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Horwitz EM, Raben A, Peters CA, Feng FY, Shipley WU, Sandler HM. Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology:Jco1802158, 2019.
  51. Santucci-Pereira J, Zeleniuch-Jacquotte A, Afanasyeva Y, Zhong H, Slifker M, Peri S, Ross EA, Lopez de Cicco R, Zhai Y, Nguyen T, Sheriff F, Russo IH, Su Y, Arslan AA, Bordas P, Lenner P, Ahman J, Landstrom Eriksson AS, Johansson R, Hallmans G, Toniolo P, Russo J. Genomic signature of parity in the breast of premenopausal women. Breast cancer research : BCR, 21(1):46, 2019.
  52. Shapovalov M, Vucetic S, Dunbrack RL, Jr. A new clustering and nomenclature for beta turns derived from high-resolution protein structures. PLoS computational biology, 15(3):e1006844, 2019.
  53. Shih JC, Olszanski AJ. Orally Administered Cancer Therapy: Breaking Down Barriers to Adherence and Quality of Life. Journal of the National Comprehensive Cancer Network, 17(3):290-2, 2019.
  54. Srivastava A, Joshi SS. Editorial Comment. The Journal of urology:10109701JU0000554385561060f, 2019. Editorial
  55. Tang JA, Lango MN. Diverging incidence trends for larynx and tonsil cancer in low socioeconomic regions of the US. Oral oncology, 91:65-8, 2019.
  56. Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O’Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G. Pancreatic Adenocarcinoma, Version 1.2019. Journal of the National Comprehensive Cancer Network, 17(3):203-10, 2019.
  57. Terry MB, Daly MB, Phillips KA, Ma X, Zeinomar N, Leoce N, Dite GS, MacInnis RJ, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, Weideman PC, Glendon G, Buchsbaum R, Andrulis IL, John EM, Buys SS, Hopper JL. Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk. Journal of the National Cancer Institute, 111(3):331-4, 2019.
  58. Thompson JA, Schneider BJ, Brahmer J, Andrews S, Armand P, Bhatia S, Budde LE, Costa L, Davies M, Dunnington D, Ernstoff MS, Frigault M, Hoffner B, Hoimes CJ, Lacouture M, Locke F, Lunning M, Mohindra NA, Naidoo J, Olszanski AJ, Oluwole O, Patel SP, Reddy S, Ryder M, Santomasso B, Shofer S, Sosman JA, Wahidi M, Wang YH, Johnson-Chilla A, Scavone JL. Management of Immunotherapy-Related Toxicities. Version 1.2019. Journal of the National Comprehensive Cancer Network, 17(3):255-88, 2019.
  59. Turchetti D, Zuntini R, Tricarico R. BRCA2 in Ovarian Development and Function. The New England journal of medicine, 380(11):1086-7, 2019. Reply
  60. Upshaw JN, O’Neill A, Carver JR, Dimond EP, Denlinger CS, Kircher SM, Wagner LI, Ky B, Brell JM. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal. Clinical Colorectal Cancer, 18(1):44-51, 2019.
  61. Wissler HL, Ehlerding EB, Lyu Z, Zhao Y, Zhang S, Eshraghi A, Buuh ZY, McGuth JC, Guan Y, Engle JW, Bartlett SJ, Voelz VA, Cai W, Wang RE. Site-Specific Immuno-PET Tracer to Image PD-L1. Molecular pharmaceutics, 2019.
  62. Yadavalli SS, Xiao Q, Sherman SE, Hasley WD, Klein ML, Goulian M, Percec V. Bioactive cell-like hybrids from dendrimersomes with a human cell membrane and its components. Proceedings of the National Academy of Sciences of the United States of America, 116(3):744-52, 2019. PMC6338876
  63. Zou KH, Evers K. Image Perception and Diagnostic Accuracy of Digital Mammography: An Editorial. Academic radiology, 2019. Editorial

Staff Publications: January 2019

  1. Ahmad AE, Kutikov A, Finelli A. Needle Tract Seeding Following Renal Tumor Biopsy: Scarcely a Concern or a Concern to Scare? European Urology. 2019 PMID: 30642611.
  2. Al-Hebshi NN, Baraniya D, Chen T, et al. Metagenome Sequencing-Based Strain-Level and Functional Characterization of Supragingival Microbiome Associated with Dental Caries in Children. Journal of Oral Microbiology. 2019;11(1):1557986. PMID: 30671194. PMC6327923.
  3. Al-Kamel A, Al-Hajj WA, Halboub E, Abdulrab S, Al-Tahami K, Al-Hebshi NN. N-Acetyl Cysteine Versus Chlorhexidine Mouthwashes in Prevention and Treatment of Experimental Gingivitis: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. Clinical Oral Investigations. 2019 PMID: 30673864.
  4. Al-Mansour Z, Li H, Cook JR, et al. Autologous Transplantation as Consolidation for High Risk Aggressive T-Cell Non-Hodgkin Lymphoma: A Swog 9704 Intergroup Trial Subgroup Analysis. Leukemia & Lymphoma. 2019:1-8. PMID: 30628511.
  5. Bellacosa A, Yen T. Illuminating the Route of Precision Medicine and Inhibitor Discovery: Real-Time Measurement of DNA Repair Capacity with Molecular Beacons. Oncotarget. 2018;9(96):36818-36819. PMID: 30627317. PMC6305151.
  6. Binder P, Wang S, Radu M, et al. Pak2 as a Novel Therapeutic Target for Cardioprotective Endoplasmic Reticulum Stress Response. Circulation Research. 2019;124(5):696-711. PMID: 30620686.
  7. Blackwell KL, Zaman K, Qin S, et al. Neratinib in Combination with Trastuzumab for the Treatment of Patients with Advanced Her2-Positive Breast Cancer: A Phase I/II Study. Clinical Breast Cancer. 2018 PMID: 30655172.
  8. Brown AF, Ma GX, Miranda J, et al. Structural Interventions to Reduce and Eliminate Health Disparities. American Journal of Public Health. 2019;109(S1):S72-S78. PMID: 30699019. PMC6356131.
  9. Chen M, Fan L, Zhang SM, et al. LINC01939 Inhibits the Metastasis of Gastric Cancer by Acting as a Molecular Sponge of miR-17-5p to Regulate EGR2 Expression. Cell Death & Disease. 2019;10(2):70. PMID: 30683847. PMC6347617.
  10. Chitalia A, Swoboda DM, McCutcheon JN, Ozdemirli M, Khan N, Cheson BD. Descriptive Analysis of Genetic Aberrations and Cell of Origin in Richter Transformation. Leukemia & Lymphoma. 2019:1-9. PMID: 30632835.
  11. Cohen EEW, Soulieres D, Le Tourneau C, et al. Pembrolizumab Versus Methotrexate, Docetaxel, or Cetuximab for Recurrent or Metastatic Head-and-Neck Squamous Cell Carcinoma (Keynote-040): A Randomised, Open-Label, Phase 3 Study. Lancet. 2019;393(10167):156-167. PMID: 30509740.
  12. Conroy JM, Pabla S, Nesline MK, et al. Next Generation Sequencing of PD-L1 for Predicting Response to Immune Checkpoint Inhibitors. Journal for Immunotherapy of Cancer. 2019;7(1):18. PMID: 30678715. PMC6346512.
  13. Crook JM, Zhang P, Pisansky TM, et al. A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer after External Beam Radiation Therapy (NRG Oncology/RTOG-0526). International Journal of Radiation Oncology, Biology, Physics. 2019;103(2):335-343. PMID: 30312717. PMC6368223.
  14. Davis SM, Lepore SJ, Dumenci L. Psychometric Properties and Correlates of a Brief Scale Measuring the Psychological Construct Mattering to Others in a Sample of Women Recovering from Breast Cancer. Quality of Life Research. 2019 PMID: 30684148.
  15. Derweesh IH, Staehler M, Uzzo RG. A Return to the Days of Radical Nephrectomy as the “Gold Standard” for Localized Renal Cell Carcinoma? Not So Fast. European Urology. 2019 PMID: 30655089.
  16. Dmitrieva-Posocco O, Dzutsev A, Posocco DF, et al. Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer. Immunity. 2019;50(1):166-180 e167. PMID: 30650375.
  17. Dumenci L, Perera RA, Keefe FJ, et al. Model-Based Pain and Function Outcome Trajectory Types for Patients Undergoing Knee Arthroplasty: A Secondary Analysis from a Randomized Clinical Trial. Osteoarthritis and Cartilage. 2019 PMID: 30660721.
  18. Falchook G, Coleman RL, Roszak A, et al. Alisertib in Combination with Weekly Paclitaxel in Patients with Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol. 2019;5(1):e183773. PMID: 30347019.
  19. Fisher JO, Serrano EL, Foster GD, et al. Efficacy of a Food Parenting Intervention for Mothers with Low Income to Reduce Preschooler’s Solid Fat and Added Sugar Intakes: A Randomized Controlled Trial. The International Journal of Behavioral Nutrition and Physical Activity. 2019;16(1):6. PMID: 30654818. PMC6335764.
  20. Frost CJ, Andrulis IL, Buys SS, et al. Assessing Patient Readiness for Personalized Genomic Medicine. J Community Genet. 2019;10(1):109-120. PMID: 29804257. PMC6325047.
  21. Gershman B, Maroni P, Tilburt JC, et al. A National Survey of Radiation Oncologists and Urologists on Prediction Tools and Nomograms for Localized Prostate Cancer. World Journal of Urology. 2019. PMID: 30671637.
  22. Gerson JN, Handorf E, Villa D, et al. Survival Outcomes of Younger Patients with Mantle Cell Lymphoma Treated in the Rituximab Era. Journal of Clinical Oncology. 2019;37(6):471-480. PMID: 30615550.
  23. Ghatalia P, Smith CH, Winer A, et al. Clinical Utilization Pattern of Liquid Biopsies (Lb) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (MCRC) Patients (PTS) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Front Oncol. 2018;8:652. PMID: 30705875. PMC6344461.
  24. Hamy AS, Tury S, Wang X, et al. Celecoxib with Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial. Journal of Clinical Oncology. 2019;37(8):624-635. PMID: 30702971.
  25. Holschneider CH, Petereit DG, Chu C, et al. Brachytherapy: A Critical Component of Primary Radiation Therapy for Cervical Cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Brachytherapy. 2019 PMID: 30665713.
  26. Huerta-Chagoya A, Moreno-Macias H, Fernandez-Lopez JC, et al. A Panel of 32 AIMs Suitable for Population Stratification Correction and Global Ancestry Estimation in Mexican Mestizos. BMC Genetics. 2019;20(1):5. PMID: 30621578. PMC6323778.
  27. Jiang X, Finucane HK, Schumacher FR, et al. Shared Heritability and Functional Enrichment across Six Solid Cancers. Nature Communications. 2019;10(1):431. PMID: 30683880. PMC6347624.
  28. Joshi S, Kutikov A. Editorial Comment. The Journal of Urology. 2017;197(2):383-384. PMID: 27821261.
  29. Kasagi Y, Dods K, Wang JX, et al. Fibrostenotic Eosinophilic Esophagitis Might Reflect Epithelial Lysyl Oxidase Induction by Fibroblast-Derived Tnf-Alpha. J Allergy Clin Immunol. 2018 PMID: 30578874.
  30. Kaur A, Ecker BL, Douglass SM, et al. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov. 2019;9(1):64-81. PMID: 30279173. PMC6328333.
  31. Kishan AU, Wang X, Seiferheld W, et al. Association of Gleason Grade with Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-Analysis. JAMA Oncol. 2019;5(1):91-96. PMID: 3032603.
  32. Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2019;17(1):64-84. PMID: 30659131.
  33. Lafata JE, Shin Y, Flocke SA, et al. Randomised Trial to Evaluate the Effectiveness and Impact of Offering Postvisit Decision Support and Assistance in Obtaining Physician-Recommended Colorectal Cancer Screening: The E-Assist: Colon Health Study-A Protocol Study. BMJ Open. 2019;9(1):e023986. PMID: 30617102. PMC6326296.
  34. MacFawn I, Wilson H, Selth LA, et al. Grainyhead-Like-2 Confers NK-Sensitivity through Interactions with Epigenetic Modifiers. Mol Immunol. 2019;105:137-149. PMID: 30508726.
  35. Mancuso P, Tricarico R, Bhattacharjee V, et al. Thymine DNA Glycosylase as a Novel Target for Melanoma. Oncogene. 2019 PMID: 30674989.
  36. Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21-34. PMID: 30554720. PMC6323553.
  37. Mikropoulos C, Selkirk CGH, Saya S, et al. Prostate-Specific Antigen Velocity in a Prospective Prostate Cancer Screening Study of Men with Genetic Predisposition. British Journal of Cancer. 2018;118(2):266-276. PMID: 29301143. PMC5785754.
  38. Miller ME, Bleicher RJ, Kaufman CS, et al. Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers. Annals of Surgical Oncology. 2019 PMID: 30684159.
  39. Milora KA, Uppalapati SR, Sanmiguel JC, Zou W, Jensen LE. Interleukin-36β Provides Protection against HSV-1 Infection, but Does Not Modulate Initiation of Adaptive Immune Responses. Scientific Reports. 2017;7(1):5799. PMID: 28724920. PMC5517484.
  40. Nam HY, Chandrashekar DS, Kundu A, et al. Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis. Molecular Cancer Research. 2019;17(1):84-96. PMID: 30131446.
  41. Necchi A, Pond GR, Moschini M, et al. Development of a Prediction Tool for Exclusive Locoregional Recurrence after Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2019;17(1):7-14 e13. PMID: 30292628.
  42. Nicolas E, Demidova EV, Iqbal W, et al. Interaction of Germline Variants in a Family with a History of Early-Onset Clear Cell Renal Cell Carcinoma. Molecular Genetics & Genomic Medicine. 2019:e556. PMID: 30680959.
  43. Pang M, Koop A, Brahmbhatt B, Bartel MJ, Woodward TA. Comparison of Flexible Endoscopic Cricopharyngeal Myectomy and Myotomy Approaches for Zenker Diverticulum Repair. Gastrointest Endosc. 2018 PMID: 30342027.
  44. Pei J, Cooper H, Flieder DB, et al. NEAT1-TfFE3 and KAT6A-TFE3 Renal Cell Carcinomas, New Members of MiT Family Translocation Renal Cell Carcinoma. Modern Pathology. 2019 PMID: 30622287.
  45. Rioux CR, Clapper ML, Cooper HS, et al. Self-Antigen MASH2 Combined with the AS15 Immunostimulant Induces Tumor Protection in Colorectal Cancer Mouse Models. PLoS One. 2019;14(1):e0210261. PMID: 30682058. PMC6347180.
  46. Rogers BB, Cuddahy T, Briscella C, Ross N, Olszanski AJ, Denlinger CS. Oxaliplatin: Detection and Management of Hypersensitivity Reactions. Clinical Journal of Oncology Nursing. 2019;23(1):68-75. PMID: 30682002.
  47. Sheikh S, Saxena D, Tian X, et al. An Integrated Stress Response Agent That Modulates DR5-Dependent TRAIL Synergy Reduces Patient-Derived Glioma Stem Cell Viability. Molecular Cancer Research. 2019 PMID: 30642878.
  48. Simmons AJ, Park R, Sterling NA, et al. Nearly Complete Deletion of BubR1 Causes Microcephaly through Shortened Mitosis and Massive Cell Death. Human Molecular Genetics. 2019 PMID: 30668728.
  49. Singh T, O’Reilly AM. Autophagy as a Beacon and Sentry for Aging Stem Cells. Autophagy. 2019:1-2. PMID: 30661483.
  50. Stinchcombe TE, Fan W, Schild SE, et al. A Pooled Analysis of Individual Patient Data from National Clinical Trials Network Clinical Trials of Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer in Elderly Patients Versus Younger Patients. Cancer. 2019;125(3):382-390. PMID: 30343497. PMC6340765.
  51. Swiecki-Sikora AL, Henry KA, Kepka D. HPV Vaccination Coverage among US Teens across the Rural-Urban Continuum. The Journal of Rural Health. 2019 PMID: 30703854.
  52. Whitcomb EA, Tsai YC, Basappa J, et al. Stabilization of P27Kip1/CDKN1B by UBCH7/UBE2L3 Catalyzed Ubiquitinylation: A New Paradigm in Cell-Cycle Control. FASEB J. 2019;33(1):1235-1247. PMID: 30113882. PMC6355086.
  53. Wierda WG, Byrd JC, Abramson JS, et al. NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019. Journal of the National Comprehensive Cancer Network. 2019;17(1):12-20. PMID: 30659125.
  54. Yao JC, Garg A, Chen D, et al. Genomic Profiling of Nets: A Comprehensive Analysis of the Radiant Trials. Endocrine-related Cancer. 2019 PMID: 30667365.
  55. Yeh I, Jorgenson E, Shen L, et al. Targeted Genomic Profiling of Acral Melanoma. Journal of the National Cancer Institute. 2019 PMID: 30657954.
  56. Yoshida H, Lareau CA, Ramirez RN, et al. The cis-Regulatory Atlas of the Mouse Immune System. Cell. 2019;176(4):897-912 e820. PMID: 30686579.
  57. Zuniga SA, Lango MN. Effect of Rural and Urban Geography on Larynx Cancer Incidence and Survival. The Laryngoscope. 2018;128(8):1874-1880. PMID: 29238975.

Accessing The Cancer Letter

Fox Chase has an institutional subscription to The Cancer Letter. To gain access, proceed as follows. 

  1. Open Firefox.
    Library materials like The Cancer Letter work best in Firefox. Please, do not use Internet Explorer.
  2. Go to the Talbot Library home page.
  3. In the Quick Links box, click on Cancer Letter.
  4. Type your Fox Chase username and password in the text boxes provided.
  5. On menu located at the top of The Cancer Letter home page, click IP Login.
    Once you click IP Login, the page will reload and Welcome, Fox Chase will appear at the top of the screen.
  6. Click PDF to download the current issue, or
    On the menu at the top of The Cancer Letter home page, click Past Issues.

EndNote X9

EndNote X9 for Mac and Windows is available for download from the Software Download Centre. We encourage all EndNote users to make backup copies of their libraries, uninstall X8, and install X9. We also encourage users to install regular updates to EndNote and Word as they are provided; this is especially true of Mac users. To have EndNote installed on your machine phone the IT Help Desk at x2800.

Over the next several weeks we will updating the EndNote LibGuide and posting about X9 here on our blog. In the meantime, here’s what’s new:

  • Enhanced reference-sharing: The library owner can set read-write access rights for other library users.
  • Manuscript matcher (EndNote and Word): Manuscript matcher uses citations in an existing paper or records in an existing library to suggest journals that might be interested in publishing your work.
  • Four new reference types: Discussion Forum, Multimedia Application, Social Media, and Television Episode.
  • Enhanced integration with Web of Science: EndNote X9 users can access Web of Science records or create a citation report from an EndNote library or group within a library
  • Sharing custom groups: EndNote X9 users can share custom groups with other EndNote Online users from *EndNote desktop.
  • View shared groups: EndNote X9 users can view a list of groups shared through EndNote online from EndNote desktop

*EndNote desktop is the version of EndNote installed on your local machine. EndNote online is the Web version of EndNote.

One-on-one EndNote training is available to Fox Chase employees. For more information about EndNote X9 or to schedule training please phone us at x2711 or email Talbot Library.



Staff Publications: December 2018

  1. Al-Hebshi NN, Nasher AT, Maryoud MY, et al. Inflammatory Bacteriome Featuring Fusobacterium Nucleatum and Pseudomonas Aeruginosa Identified in Association with Oral Squamous Cell Carcinoma. Sci Rep. 2017;7(1):1834. PMID: 28500338. PMC5431832.
  2. Bai T, Chanda AK, Egleston BL, Vucetic S. EHR Phenotyping via Jointly Embedding Medical Concepts and Words into a Unified Vector Space. BMC Med Inform Decis Mak. 2018;18(Suppl 4):123. PMID: 30537974. PMC6290514.
  3. Bair SM, Strelec LE, Feldman TA, et al. Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis. Oncologist. 2018. PMID: 30568021.
  4. Bergman A, Gligorijevic B. Real-Time Imaging of Invadopodia in Tumor Microenvironment Context. (2018) Optics InfoBase Conference Papers, Part F89-MICROSCOPY 2 p.
  5. Cheson BD, O’Brien S, Ewer MS, et al. Optimal Management of Adverse Events from Copanlisib in the Treatment of Patients with Non-Hodgkin Lymphomas. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30584024.
  6. Correa AF, Yankey H, Li T, et al. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2019;123:174-180. PMID: 30296503.
  7. de Prisco N, Stout E, Font-Burgada J. Specific Labeling and Lineage Tracing of Periportal Hepatocytes Using Two-Step Genetic Recombination. Methods Mol Biol. 2019;1905:59-70. PMID: 30536090.
  8. Dignam JJ, Hamstra DA, Lepor H, et al. Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202. J Clin Oncol. 2018:JCO1800154. PMID: 30526194.
  9. Dyer KE, Shires DA, Flocke SA, et al. Patient-Reported Needs Following a Referral for Colorectal Cancer Screening. Am J Prev Med. 2018. PMID: 30554975.
  10. Edwards DC, Cahn DB, Reddy M, et al. Incisional Hernia after Cystectomy: Incidence, Risk Factors and Anthropometric Predisposition. Can J Urol. 2018;25(6):9573-9578. PMID: 30553281.
  11. Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving Landscape of the Treatment of Metastatic Clear Cell Renal Cell Carcinoma. Clin Adv Hematol Oncol. 2018;16(10):677-686. PMID: 30543598.
  12. Gotlib J, Gerds AT, Bose P, et al. Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(12):1500-1537. PMID: 30545997.
  13. Gounder MM, Mahoney MR, Van Tine BA, et al. Sorafenib for Advanced and Refractory Desmoid Tumors. N Engl J Med. 2018;379(25):2417-2428. PMID: 30575484.
  14. Graves KD, Hall MJ, Tercyak KP. Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for Translational Behavioral Medicine Research, Practice, and Policy. Transl Behav Med. 2018;8(1):4-6. PMID: 29385593. PMC6065537.
  15. Haddad RI, Nasr C, Bischoff L, et al. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. J Natl Compr Canc Netw. 2018;16(12):1429-1440. PMID: 30545990.
  16. Hendifar AE, Petzel MQB, Zimmers TA, et al. Pancreas Cancer-Associated Weight Loss. Oncologist. 2018. PMID: 30591550.
  17. Hernandez Borrero LJ, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018;78(10):2770-2771. PMID: 29703721.
  18. Heyza JR, Arora S, Zhang H, et al. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells. Nutrients. 2018;10(11). PMID: 30400270. PMC6267282.
  19. Ito T, Derweesh IH, Ginzburg S, et al. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017;197(1):31-36. PMID: 27418453.
  20. Jones CE, Hammer AM, Cho Y, et al. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia. 2019;21(1):132-145. PMID: 30550871. PMC6293034.
  21. Kasagi Y, Dods K, Wang JX, et al. Fibrostenotic Eosinophilic Esophagitis May Reflect Epithelial Lysyl Oxidase Induction by Fibroblasts-Derived Tumor Necrosis Factor-Alpha. J Allergy Clin Immunol. 2018. PMID: 30578874.
  22. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an Fda and Critical Path Institute Workshop. Value Health. 2018;21(6):742-747. PMID: 29909880.
  23. Kozlova AL, Valieva ME, Maluchenko NV, Studitsky VM. HMGB Proteins as DNA Chaperones That Modulate Chromatin Activity. Molecular Biology. 2018;52(5):637-647.
  24. Liao L, Alicea-Velazquez NL, Langbein L, et al. High Affinity Binding of H3K14AC through Collaboration of Bromodomains 2, 4, and 5 is Critical for the Molecular and Tumor Suppressor Functions of PBRM1. Mol Oncol. 2018. PMID: 30585695.
  25. Lin T, Hossain M, Fan J, Ma CC. When and How to Treat an IMRT Patient on a Second Accelerator without Replanning? Med Dosim. 2018;43(4):334-343. PMID: 29287919.
  26. Liu B, Tang L, Zhang X, et al. A Cell-Based High Throughput Screening Assay for the Discovery of CGAS-STING Pathway Agonists. Antiviral Res. 2017;147:37-46. PMID: 28982551. PMC5789800. NIHMS911402.
  27. Lu H, Liu S, Zhang G, et al. Author Correction: PAK Signalling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-Mutant Melanomas. Nature. 2019;565(7738):E4. PMID: 30532003.
  28. MacFawn I, Wilson H, Selth LA, et al. Grainyhead-Like-2 Confers NK-Sensitivity through Interactions with Epigenetic Modifiers. Mol Immunol. 2018;105:137-149. PMID: 30508726.
  29. Magnius L, Taylor J, Mason WS, et al. ICTV Virus Taxonomy Profile: Deltavirus. J Gen Virol. 2018;99(12):1565-1566. PMID: 30311870.
  30. Martin JM, Wu H, Barta SK. Cd30+ T-Cell Lymphoproliferative Disorders. Chin Clin Oncol. 2018. PMID: 30525751.
  31. Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21-34. PMID: 30554720.
  32. Ming M, Wu W, Xie B, et al. XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB. Mol Cancer Ther. 2018;17(12):2564-2574. PMID: 3051014.
  33. Mortazavi SAR, Kadivar F, Mortazavi SMJ. Comments on, “A Narrative Review of Interventions for Improving Sleep and Reducing Circadian Disruption in Medical Inpatients”. Sleep Med. 2018. PMID: 30503687.
  34. Parham LR, Williams PA, Chatterji P, Whelan KA, Hamilton KE. RNA Regulons Are Essential in Intestinal Homeostasis. Am J Physiol Gastrointest Liver Physiol. 2019;316(1):G197-G204. PMID: 30520692.
  35. Pourfarhangi KE, Bayarmagnai B, de la Hoz EC, Cohen A, Gligorijevic B. A Methodology to Investigate the Relationship between Cancer Cells Cell-Cycle Phase and Their Migratory Behaviors. Optics InfoBase Conference Papers, Part F91-TRANSLATIONAL. 2 p. 2018.
  36. Prabhu VV, Madhukar NS, Gilvary C, et al. Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. Clin Cancer Res. 2018. PMID: 30559168.
  37. Ramos JD, Wingate JT, Gulati R, et al. Venous Thromboembolism Risk in Patients with Locoregional Urothelial Tract Tumors. Clin Genitourin Cancer. 2017;16(1):e161-e167. PMID: 28923700. PMC5826750.
  38. Redner RL, Beumer JH, Kropf P, et al. A Phase-1 Study of Dasatinib plus All-Trans Retinoic Acid in Acute Myeloid Leukemia. Leuk Lymphoma. 2018;59(11):2595-2601. PMID: 29616864. PMC6201295.
  39. Reese JB, Smith KC, Handorf E, et al. A Randomized Pilot Trial of a Couple-Based Intervention Addressing Sexual Concerns for Breast Cancer Survivors. J Psychosoc Oncol. 2018:1-22. PMID: 30580675.
  40. Reese JB, Sorice KA, Oppenheimer NM, et al. Why Do Breast Cancer Survivors Decline a Couple-Based Intimacy Enhancement Intervention Trial? Transl Behav Med. 2018. PMID: 30544201.
  41. Roethke SK, Ryan JC, Wood SY. Management of Older Patients with Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario. J Adv Pract Oncol. 2018;9(1):67-76. PMID: 30564469. PMC6296420.
  42. Roussi P, Miller SM, Giri VN, et al. Effects of a Randomized Trial Comparing Standard and Enhanced Counseling for Men at High Risk of Prostate Cancer as a Function of Race and Monitoring Style. J Health Psychol. 2016;23(14):1359105316671188. PMID: 28810355. PMC5561513.
  43. Shulman RM, Meyer JE, Li T, Howell KJ. External Beam Radiation Therapy (EBRT) for Asymptomatic Bone Metastases in Patients with Solid Tumors Reduces the Risk of Skeletal-Related Events (SRES). Ann Palliat Med. 2018. PMID: 30525770.
  44. Su Y, Hopfinger NR, Nguyen TD, Pogash TJ, Santucci-Pereira J, Russo J. Epigenetic Reprogramming of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer Cells with DNA Methyltransferase and Histone Deacetylase Inhibitors. J Exp Clin Cancer Res. 2018;37(1):314. PMID: 30547810. PMC6295063.
  45. Walpole S, Pritchard AL, Cebulla CM, et al. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. J Natl Cancer Inst. 2018;110(12):1328-1341. PMID: 30517737. PMC6292796.
  46. White MN, Dotan E, Catalano PJ, Cardin DB, Berlin JD. Advanced Pancreatic Cancer Clinical Trials: The Continued Underrepresentation of Older Patients. J Geriatr Oncol. 2018. PMID: 30573201.
  47. Wickersham KE, Hodges TK, Edelman MJ, Song Y, Nan M, Dorsey SG. Differential Gene Expression in Erlotinib-Treated Fibroblasts. Nurs Res. 2018. PMID: 30540703.
  48. Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures into Future Successes. Mol Cancer Ther. 2018;17(6):1147-1155. PMID: 29735645. PMC5984693.
  49. Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE. Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis. Am J Clin Oncol. 2019;42(1):46-55. PMID: 29965809.